S100 proteins are emerging as promising biomarkers and therapeutic targets, with significant potential in lung diseases, such as elevated levels of S100A8/A9 (calprotectin) correlating with severe COVID-19 and cytokine storms, which suggests their utility as predictive markers. Here, S100A1 is linked to COVID-19.